Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 8610884002

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    173

Stocks News & Analysis

stocks

Earnings from our top global lithium pick

Shares rise on improved free cash flow generation.
stocks

After slump this ASX share may be an opportunity

Lower than expected guidance led to a sell-off.
stocks

Investment decisions in overvalued bank drive strong results

Shares fall despite a broadly unchanged outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,098.4053.80-0.59%
CAC 408,107.5152.000.65%
DAX 4023,990.8030.810.13%
Dow JONES (US)47,368.63381.530.81%
FTSE 1009,864.6377.480.79%
HKSE26,696.4147.350.18%
NASDAQ23,527.17522.642.27%
Nikkei 22550,842.9368.83-0.14%
NZX 50 Index13,604.5512.93-0.09%
S&P 5006,832.43103.631.54%
S&P/ASX 2008,818.8056.80-0.64%
SSE Composite Index4,002.7615.84-0.39%

Market Movers